hrp0097p2-17 | Growth and Syndromes | ESPE2023

Efficacy and safety of recombinant growth hormone therapy in a girl with a Loeys-Dietz syndrome

Dyrka Kamil , Tomaszewska Andzelika , Balcerzak Justyna , Aniol Zuzanna , Niedziela Marek , Obara-Moszynska Monika

The Loeys-Dietz syndrome (LDS) is a genetic heterogeneous, autosomal dominant aortic aneurysm syndrome with widespread systemic involvement. As defined by Loeys et al. (2006), the disorder is characterized by the triad of arterial tortuosity and aneurysms, hypertelorism, and bifid uvula or cleft palate. We present a 16.5-year-old girl with LDS2 caused by a mutation c.1582C>T (p.R5228C) in the TGFBR2 gene and treated with recombinant growth hormone (rGH) du...